Adaptive trials of new antimicrobials for infections with carbapenem-resistant, Gram-negative bacteria

Lancet Infect Dis. 2020 Jan;20(1):24. doi: 10.1016/S1473-3099(19)30704-2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents*
  • Carbapenems
  • Drug Resistance, Bacterial / drug effects
  • Gram-Negative Bacteria / drug effects
  • Humans
  • Infections*
  • Marketing

Substances

  • Anti-Bacterial Agents
  • Carbapenems